FDA issued a Warning Letter to Valeant Pharmacueticals International on 11/3/2016 for a later inspection.
483 Valeant Pharmacueticals North America Jul 2015

483 Valeant Pharmacueticals North America Jul 2015

Jennifer Custodio FDA, Doreen Gubbay FDA, Frank Marciniak FDA$119.00 - Available Now

FDA investigators audited the Valeant Pharmacueticals North America - Rochester, NY, United States facility and issued 17 inspectional observations (via FDA 483) on 28 Jul 2015.

Product details

  • Category: Medical Devices & Rad Health / Human Drugs
  • Number of Observations: 17
  • Inspection end: 28 Jul 2015
  • Location: Rochester, United States
  • FEI: 3009443653
Add To Cart